News
The US Department of Health and Human Services has terminated 22 mRNA vaccine research contracts under BARDA, signaling a ...
The biotech company extends its Phase I trial (NCT06252220) of DA-1726 to eight weeks following encouraging early efficacy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback